Publications
Explore GRIPonMASH's latest insights on liver disease research. Stay informed with our in-depth analysis and expert perspectives.
Rationale and Design of a Prospective Multicenter Study
Global Research Initiative for Patient Screening on MASH (GRIPonMASH) protocol.The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) may be as high as 38% in the adult population with potential serious complications, multiple co-morbidities and a high socioeconomic burden.
